Back to methods browser

First-pass extracted concept

network pharmacology

Candidate: toolkit itemType: computation method1 source documents4 linked claims
Jump to explainersJump to evidenceJump to sourcesJump to claims
Live refresh every 5sNext refresh in 5s

Extracted Explainers

What the tool is doing

Network pharmacology was used to identify active ingredients from ZRGCDMD, identify disease-associated targets, and analyze enriched pathways. In this paper it serves as the main computational framework for multitarget mechanism discovery.

Source 1DOIPubMed

Resources required

The abstract indicates that ingredient lists, disease-associated targets, and downstream GO/KEGG analyses are required inputs. The upstream summary also points to database-backed resource use, but the abstract alone does not fully specify all databases.

Source 1DOIPubMed

What problem it solves

It helps analyze how a multicomponent decoction could act through multiple targets and pathways rather than a single target. This is useful for mechanism exploration in insomnia comorbid with depression.

Source 1DOIPubMed

What it does not solve

The abstract does not show that network pharmacology alone establishes causal therapeutic efficacy in biological experiments. It provides candidate mechanisms rather than direct functional validation.

Source 1DOIPubMed

Alternatives

The paper pairs network pharmacology with molecular docking as a complementary computational approach. No other alternative engineering or assay method is explicitly contrasted in the abstract.

Source 1DOIPubMed

Evidence Snippets

Using network pharmacology, 244 active ingredients were identified from ZRGCDMD, with key components including baicalein, β-carotene, kaempferol, quercetin, naringenin, and diosgenin.
Evidence 1Source 1DOIPubMedprovenance

Supporting Sources

Linked Claims

Claim 1identified component countsupports2026Source 1DOIPubMed

Network pharmacology identified 244 active ingredients from ZRGCDMD.

Quoted textsource-backed
Using network pharmacology, 244 active ingredients were identified from ZRGCDMD
Claim 2identified target countsupports2026Source 1DOIPubMed

Eighty-eight targets associated with depression comorbid with insomnia were identified.

Quoted textsource-backed
Additionally, 88 targets associated with depression comorbid with insomnia were identified.
Claim 3mechanism summarysupports2026Source 1DOIPubMed

Zao Ren Gan Cao Da Mai decoction was studied with network pharmacology and molecular docking to explore its multitarget mechanism in insomnia comorbid with depression.

Quoted textsource-backed
This study employs network pharmacology and molecular docking techniques to uncover the mechanisms by which ZRGCDMD treats depression associated with insomnia.
Claim 4pathway enrichmentsupports2026Source 1DOIPubMed

GO and KEGG analyses indicated that ZRGCDMD may act through neuroactive ligand-receptor interactions, lipid metabolism, and the AGE-RAGE signaling pathway.

Quoted textsource-backed
Gene ontology and Kyoto encyclopedia of genes and genomes analyses revealed that ZRGCDMD operates through pathways including neuroactive ligand-receptor interactions, lipid metabolism, and the AGE-RAGE signaling pathway.